Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Longer TA repeats in the SRD5A2 gene may increase acne risk in Chinese people.

Herbal treatments can help manage PCOS symptoms.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Finasteride reduces hair growth better, but spironolactone has more side effects.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

More than half of the young women checked had PCOS, which was linked to inactive lifestyles and poor diets.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Women with PCOS have more Bifidobacterium in their gut compared to those without PCOS.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Flutamide worked better than finasteride for reducing excessive hair growth in women, but had more side effects.

Hormones, especially androgens, play a key role in causing acne, and treatments like hormone control pills and hormone-blocking medications can help.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

PCOS is a common hormonal disorder in women that can lead to serious health problems.

Ayurvedic treatment and Yoga Basti therapy improved a woman's PCOS symptoms.